JPH04173781A - Thiazoleacetic acid derivative - Google Patents
Thiazoleacetic acid derivativeInfo
- Publication number
- JPH04173781A JPH04173781A JP2298660A JP29866090A JPH04173781A JP H04173781 A JPH04173781 A JP H04173781A JP 2298660 A JP2298660 A JP 2298660A JP 29866090 A JP29866090 A JP 29866090A JP H04173781 A JPH04173781 A JP H04173781A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- formula
- compound
- added
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BYHXLDZDSZVDJH-UHFFFAOYSA-N acetic acid;1,3-thiazole Chemical class CC(O)=O.C1=CSC=N1 BYHXLDZDSZVDJH-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 26
- 150000003839 salts Chemical class 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims 1
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 abstract description 9
- 229930186147 Cephalosporin Natural products 0.000 abstract description 7
- 229940124587 cephalosporin Drugs 0.000 abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract description 6
- 150000008065 acid anhydrides Chemical class 0.000 abstract description 5
- 150000001780 cephalosporins Chemical class 0.000 abstract description 5
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract description 4
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 238000006170 formylation reaction Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract description 2
- 235000019253 formic acid Nutrition 0.000 abstract description 2
- URGSBEYHHRKMJL-UHFFFAOYSA-N 2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetic acid Chemical compound NC1=NC(C(=NO)C(O)=O)=CS1 URGSBEYHHRKMJL-UHFFFAOYSA-N 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 26
- -1 7-aminocephem compound Chemical class 0.000 description 25
- 239000000243 solution Substances 0.000 description 17
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- PFBUKDPBVNJDEW-UHFFFAOYSA-N dichlorocarbene Chemical group Cl[C]Cl PFBUKDPBVNJDEW-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 5
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- 239000012267 brine Substances 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- AMJKOBONJUKTSC-OQFOIZHKSA-N (2z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetamide Chemical group NC(=O)C(=N/O)\C1=CSC(N)=N1 AMJKOBONJUKTSC-OQFOIZHKSA-N 0.000 description 1
- FJPNAQRDSFZHJM-FSRJSHLRSA-N (2z)-2-(oxan-2-yloxyimino)-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetic acid Chemical compound C=1SC(NC(C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=NC=1/C(C(=O)O)=N/OC1CCCCO1 FJPNAQRDSFZHJM-FSRJSHLRSA-N 0.000 description 1
- VGRXAHXMIDCTNV-UHFFFAOYSA-N (6-chlorobenzotriazol-1-yl) 4-chlorobenzenesulfonate Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)ON1C2=CC(Cl)=CC=C2N=N1 VGRXAHXMIDCTNV-UHFFFAOYSA-N 0.000 description 1
- MAUMSNABMVEOGP-UHFFFAOYSA-N (methyl-$l^{2}-azanyl)methane Chemical compound C[N]C MAUMSNABMVEOGP-UHFFFAOYSA-N 0.000 description 1
- 125000004512 1,2,3-thiadiazol-4-yl group Chemical group S1N=NC(=C1)* 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical group ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- YKECSFNZQGAHFU-UHFFFAOYSA-N 2-iminoacetamide Chemical compound NC(=O)C=N YKECSFNZQGAHFU-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- RNJFNMVAKBJPCI-UHFFFAOYSA-N C(=O)NC=1SC=C(N1)C(C(=O)O)=NOC=O Chemical compound C(=O)NC=1SC=C(N1)C(C(=O)O)=NOC=O RNJFNMVAKBJPCI-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- PBZUAIHRZUBBAJ-UHFFFAOYSA-N Hydroxyiminoacetic acid Natural products ON=CC(O)=O PBZUAIHRZUBBAJ-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical class CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- BQYAYJLTUMUXEP-UHFFFAOYSA-N N-(2,2-dichloroethenyl)-N-methylformamide Chemical compound ClC(Cl)=CN(C=O)C BQYAYJLTUMUXEP-UHFFFAOYSA-N 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- HVONASJQEPJWNJ-UHFFFAOYSA-M [Na+].[O-]C(=O)C=N Chemical compound [Na+].[O-]C(=O)C=N HVONASJQEPJWNJ-UHFFFAOYSA-M 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000003946 cyclohexylamines Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- GRWIABMEEKERFV-UHFFFAOYSA-N methanol;oxolane Chemical compound OC.C1CCOC1 GRWIABMEEKERFV-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- LZTRCELOJRDYMQ-UHFFFAOYSA-N triphenylmethanol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)C1=CC=CC=C1 LZTRCELOJRDYMQ-UHFFFAOYSA-N 0.000 description 1
- JBWKIWSBJXDJDT-UHFFFAOYSA-N triphenylmethyl chloride Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Cl)C1=CC=CC=C1 JBWKIWSBJXDJDT-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Landscapes
- Thiazole And Isothizaole Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は抗菌活性に優れたセファロスポリン類を製造す
るための中間体として有用な下記式で示されるポルミル
オキシイミノ−2−(2−ホルミルアミノチアゾール−
4−イル)酢酸並びにその塩及び反応性誘導体に関する
。DETAILED DESCRIPTION OF THE INVENTION The present invention provides pormyroxyimino-2-(2-formylaminothiazole-
4-yl)acetic acid and its salts and reactive derivatives.
従来、(Z)−2−(2−1リチルアミノチアゾール−
4−イル)−2−トリチルオキシイミノ酢酸(1)又は
(Z)−2−(2−トリチルアミノチアゾール−4−イ
ル)−2−テトラヒドロピラニルオキシイミノ酢酸(2
)等を7−アミノセフェム化合物と反応させた後、保護
基を除去することにより、7− [(Z)−2−(2−
アミノチアゾール−4−イル)−2−ヒドロキシイミノ
アセトアミド]基を有するセファロスポリン誘導体を製
造する方法は公知である[R,Bucourt et。Conventionally, (Z)-2-(2-1 lytylaminothiazole-
4-yl)-2-trityloxyiminoacetic acid (1) or (Z)-2-(2-tritylaminothiazol-4-yl)-2-tetrahydropyranyloxyiminoacetic acid (2
) etc. with a 7-aminocephem compound and then removing the protecting group to form 7-[(Z)-2-(2-
A method for preparing cephalosporin derivatives having the aminothiazol-4-yl)-2-hydroxyiminoacetamide group is known [R, Bucourt et.
al、、 Tetrahedron、 1978.34
.2233 :特開昭56−21600号公報参照]。al., Tetrahedron, 1978.34
.. 2233: see Japanese Unexamined Patent Publication No. 56-21600].
(L)(え)
しかしながら、上記方法において原料として使用される
(1)又は(2)の化合物は、ジヒドロビラン、塩化ト
リチル等の高価な試薬を用いて製造されるものであり、
工業的に採用し難い。また、保護基(トリチル基)の脱
離行程で反応を完全に終結されることが困難であり、そ
のため目的とするセファロスポリン誘導体の収率も充分
に満足できるものではない。さらに、上記方法では、保
護基の脱離行程でトリフェニルカルビノールが副生する
が、その分離除去処理が煩雑であるという欠点があり、
上記の方法は工業的規模での製造法としては好ましいも
のとはいえない。(L) (e) However, the compound (1) or (2) used as a raw material in the above method is produced using expensive reagents such as dihydrobilane and trityl chloride.
Difficult to adopt industrially. Furthermore, it is difficult to completely terminate the reaction in the step of removing the protecting group (trityl group), and therefore the yield of the desired cephalosporin derivative is not fully satisfactory. Furthermore, in the above method, triphenylcarbinol is produced as a by-product in the step of removing the protecting group, but the separation and removal process is complicated.
The above method cannot be said to be preferable as a production method on an industrial scale.
これに対し、今回、本発明により提供される前記式(I
)で示されるホルミルオキジイミノ−2−(2−ホルミ
ルアミノチアゾール−4−イル)酢酸並びにその塩及び
反応性誘導体は、上記式(1)又は(2)の化合物にみ
られるような欠点がなく、(Z)−2−(2−アミノチ
アゾール−4−イル)−2−ヒドロキシイミノアセトア
ミド基を7位に有する抗菌活性に優れたセファロスポリ
ン化合物の製造中間体として極めて有用であることを見
い出し、本発明を完成するに至った。On the other hand, the formula (I
Formyloxyimino-2-(2-formylaminothiazol-4-yl)acetic acid and its salts and reactive derivatives represented by However, it is extremely useful as an intermediate for the production of cephalosporin compounds having excellent antibacterial activity and having a (Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide group at the 7-position. This finding led to the completion of the present invention.
前記式(1)において、ホルミルオキジイミノ基はZ−
型(5yn−型)又はE−型(anti−型)のいずれ
かの立体配置を有することができるが、一般にZ−異性
体が好適である。In the above formula (1), the formyloxydiimino group is Z-
Although it can have either the (5yn-) or the E- (anti-) configuration, the Z-isomer is generally preferred.
式(I)の化合物は塩の形で存在することができ、その
ような塩としては、例えば、ナトリウム塩、カリウム塩
などのアルカリ金属塩;マグネシウム塩、亜鉛塩などの
アルカリ土類金属塩;アンモニウム塩、トリエチルアミ
ン塩、シクロヘキンルアミン塩、N、N−ジメチルアニ
リン塩、モルホリンなどの有機アミン塩、等が挙げられ
る。The compounds of formula (I) can exist in the form of salts, such as, for example, alkali metal salts such as sodium salts, potassium salts; alkaline earth metal salts such as magnesium salts, zinc salts; Organic amine salts such as ammonium salts, triethylamine salts, cyclohexylamine salts, N,N-dimethylaniline salts, and morpholine can be mentioned.
また、式(I)の化合物の反応性誘導体には、カルボン
酸のアシルアミド形成性反応性誘導体が包含され、具体
的には、例えば、クロリド、プロミドなどのハライド:
ジアルキル燐酸混合酸無水物、アルキル炭酸混合酸無水
物、芳香族酸無水物などの無水物ニトリアゾール、テト
ラゾールなどとの酸アミド;ジメチルイミノメチル
+
[(CH3)2N = CH−]エステル、p−ニトロ
フェニルニス7−/I/、2.4−ジニトロフェニルエ
ステル、N−ヒドロキシベンゾトリアゾールエステルな
どの活性エステル、等が挙げられる。Reactive derivatives of the compound of formula (I) also include acylamide-forming reactive derivatives of carboxylic acids, specifically halides such as chloride and bromide:
Acid amides with anhydrides such as dialkyl phosphoric mixed acid anhydrides, alkyl carbonic acid mixed acid anhydrides, aromatic acid anhydrides, nitriazole, tetrazole, etc.; dimethyliminomethyl + [(CH3)2N = CH-] ester, p- Active esters such as nitrophenyl varnish 7-/I/, 2,4-dinitrophenyl ester, N-hydroxybenzotriazole ester, and the like.
本発明の式(I)の化合物は、例えば、それ自体既知の
方法(例えば、特開昭52−102293号公報記載の
方法)により製造される下記式で示される2−ヒドロキ
シイミノ−2−(2−アミノチアゾール−4−イル)酢
酸をホルミル化することにより容易に製造することがで
きる。The compound of formula (I) of the present invention is, for example, a 2-hydroxyimino-2-( It can be easily produced by formylating 2-aminothiazol-4-yl)acetic acid.
式(n)の化合物のホルミル化は、式(II)の化合物
に、ギ酸と無水酢酸とから調製される混合酸無水物を反
応させることにより行なうことができる。該混合酸無水
物の使用量は一般に、式(Iりの化合物1モル当り2〜
50モル、好ましくは4〜10モルの範囲内が適当であ
る。Formylation of the compound of formula (n) can be carried out by reacting the compound of formula (II) with a mixed acid anhydride prepared from formic acid and acetic anhydride. The amount of mixed acid anhydride used is generally from 2 to 1 mole of compound of formula (I).
A suitable amount is 50 mol, preferably 4 to 10 mol.
上記ホルミル化反応は溶媒なしで行なうこともできるが
、通常は例えばアセトニトリル、ジクロロメタン、酢酸
エチル、テトラヒドロフラン、ジオキサン、アセトン等
の反応に不活性な溶媒中で行なうのが好都合である。ま
た、反応温度は一般に約−20〜100℃、好ましくは
約−10〜60℃の範囲内とすることができる。かくし
て得られる式(I)の化合物はそれ自体既知方法、例え
ば結晶化、−過、洗浄、乾燥等の方法により反応終了後
の反応混合物から分離、精製することができる。Although the formylation reaction can be carried out without a solvent, it is usually convenient to carry out it in a solvent inert to the reaction, such as acetonitrile, dichloromethane, ethyl acetate, tetrahydrofuran, dioxane, acetone, or the like. Further, the reaction temperature can generally be in the range of about -20 to 100°C, preferably about -10 to 60°C. The compound of formula (I) thus obtained can be separated and purified from the reaction mixture after completion of the reaction by methods known per se, such as crystallization, filtration, washing, drying and the like.
また、式(I)の化合物の塩は、それ自体既知の造塩反
応を利用して製造することができ、例えば、式(I)の
化合物を、水酸化ナトリウム、水酸化カリウム、炭酸水
素ナトリウム、炭酸水素カリウム、アンモニア、トリエ
チルアミン等の塩基と反応させることにより製造するこ
とができる。Further, the salt of the compound of formula (I) can be produced using a salt-forming reaction known per se. For example, the salt of the compound of formula (I) can be prepared by mixing the compound of formula (I) with sodium hydroxide, potassium hydroxide, sodium hydrogen carbonate, etc. , potassium hydrogen carbonate, ammonia, triethylamine, and other bases.
この反応は通常、N、N−ジメチルホルムアミド、ジメ
チルスルホキシド、アセトン、アセトニトリル、水等の
溶媒中で約−30〜100℃、好ましくは約−15〜3
0℃の温度で行なうことができる。This reaction is usually carried out in a solvent such as N,N-dimethylformamide, dimethyl sulfoxide, acetone, acetonitrile, water, etc. at about -30 to 100°C, preferably about -15 to 300°C.
It can be carried out at a temperature of 0°C.
また、式(I)の化合物の反応性誘導体は、例えば、式
(I)の化合物を、五塩化リン、塩化チオニル、塩化オ
キザリル、オキシ塩化リン、三塩化リン、ポリリン酸エ
チル、N、N−ジシクロへキシルカルボジイミド、1−
(p−クロロベンゼンスルホニルオキシ)−6−クロロ
−IH−ベンゾトリアゾール、ジメチルホルムアミドと
塩化チオニル、オキシ塩化リンとの反応によって調製さ
れるビルスマイヤー試薬、等の化合物と、通常冷却下な
いし常温で反応させることにより製造することができる
。In addition, reactive derivatives of the compound of formula (I) include, for example, phosphorus pentachloride, thionyl chloride, oxalyl chloride, phosphorus oxychloride, phosphorus trichloride, ethyl polyphosphate, N, N- dicyclohexylcarbodiimide, 1-
React with a compound such as (p-chlorobenzenesulfonyloxy)-6-chloro-IH-benzotriazole, Vilsmeier's reagent prepared by the reaction of dimethylformamide with thionyl chloride, or phosphorus oxychloride, usually under cooling or at room temperature. It can be manufactured by
本発明により提供される前記式(I)の2−ホルミルオ
キシイミノ−2−(2−ホルミルアミノチアゾール−4
−イル)酢酸並びにその塩及び反応性誘導体(以下、本
発明化合物という)は、抗菌活性を有するセファロスポ
リン誘導体を製造するための中間体として有用である。2-formyloxyimino-2-(2-formylaminothiazole-4) of the formula (I) provided by the present invention
-yl)acetic acid and its salts and reactive derivatives (hereinafter referred to as compounds of the present invention) are useful as intermediates for producing cephalosporin derivatives having antibacterial activity.
例えば、本発明化合物を下記式
式中、R1は水素原子又はカルボキシ保護基を表わし、
R2は水素原子又はセファロスポリン化合物に通常みら
れる3位置換基を表わす、
で示される7−アミノセフェム化合物と反応させて下記
式
%式%
式中、R1及びR2は上記定義のとおりである、で示さ
れる化合物を生成せしめ、次いで加水分解することによ
り下記式
式中、R,及びR2は前記定義のとおりである、で示さ
れるセファロスポリン誘導体に導くことができる。For example, the compound of the present invention is represented by the following formula, where R1 represents a hydrogen atom or a carboxy protecting group,
R2 represents a hydrogen atom or a 3-position substituent commonly found in cephalosporin compounds, and is reacted with a 7-aminocephem compound represented by the following formula % formula % where R1 and R2 are as defined above. By producing a compound represented by , and then hydrolyzing it, a cephalosporin derivative represented by the following formula, where R and R2 are as defined above, can be obtained.
本発明化合物と式(II[)の化合物との反応は、例え
ばアセトン、テトラヒドロフラン、酢酸エチル、ジクロ
ロメチレン、N、N−ジメチルホルムアミド又はこれら
と水との混合溶媒等の反応に不活性な溶媒中において、
アルカリ金属炭酸水素塩、トリアルキルアミン、ピリジ
ン、N、N−アルキルベンジルアミン等の無機塩基又は
有機塩基の存在下に、通常冷却下ないし常温で実施する
ことができる。The reaction between the compound of the present invention and the compound of formula (II[) can be carried out in a solvent inert to the reaction, such as acetone, tetrahydrofuran, ethyl acetate, dichloromethylene, N,N-dimethylformamide, or a mixed solvent of these and water. In,
The reaction can be carried out in the presence of an inorganic or organic base such as an alkali metal hydrogen carbonate, trialkylamine, pyridine, N,N-alkylbenzylamine, etc., usually under cooling or at room temperature.
生成する式(rV)の化合物の加水分解は、一般に、触
媒量ないし大過剰量の酸、例えば塩酸、硫酸、リン酸等
の存在下に、約−10〜100℃、好ましくは約O〜4
0℃の温度で約0.5〜24時間かけて行なうことがで
きる。反応にあたって、メタノール、エタノール、ジオ
キサン、アセトン、テトラヒドロフラン等の溶媒を使用
することが好適である。Hydrolysis of the resulting compound of formula (rV) is generally carried out in the presence of a catalytic amount to a large excess of an acid, such as hydrochloric acid, sulfuric acid, phosphoric acid, etc., at a temperature of about -10 to 100°C, preferably about 0 to 4
It can be carried out at a temperature of 0° C. for about 0.5 to 24 hours. In the reaction, it is preferable to use a solvent such as methanol, ethanol, dioxane, acetone, or tetrahydrofuran.
次に実施例により本発明をさらに具体的に説明する。Next, the present invention will be explained in more detail with reference to Examples.
実施例1
ギ酸(11,3論ρ、0.3mol)に無水酢酸(28
,3+L 0.3mol)を加えた後、50℃で1時間
かくはんした。この反応液を室温に戻し、(Z)−2−
(2−アミノチアゾール−4−イル)−2=ヒドロキシ
イミノ酢酸(5,61g、 0.03mol)を加え室
温で16時間かくはんした。反応液をイソプロピルエー
テル(400Jりに加えた後、析出物を濾過した。濾過
物をイソプロピルエーテルで洗浄し、乾燥し、無色結晶
状化合物として、(Z)−2−(2−ホルミルアミノチ
アゾール−4−イル)−2−ホルミルオキシイミノ酢酸
(5゜95g1収率:82%)を得た。Example 1 Acetic anhydride (28
, 3+L 0.3 mol) and then stirred at 50°C for 1 hour. This reaction solution was returned to room temperature, and (Z)-2-
(2-Aminothiazol-4-yl)-2=hydroxyiminoacetic acid (5.61 g, 0.03 mol) was added and stirred at room temperature for 16 hours. After adding the reaction solution to isopropyl ether (400 J), the precipitate was filtered. The filtrate was washed with isopropyl ether and dried to give (Z)-2-(2-formylaminothiazole-) as a colorless crystalline compound. 4-yl)-2-formyloxyiminoacetic acid (5.95 g/yield: 82%) was obtained.
mp:188〜192℃(分解)
I R(KBr、 disc、、 cr’) 3200
.3110.2950.1775.1770.1745
.1700.1635.1555.1400、1295
.1210.1120.1050゜955.865.7
5O
NMR(DMSO−d6.δ)8.16 (s、IH
)8.31 (s、IH)8.60 (IH,s)
実施例2
(Z)−2−(2−ホルミルアミノチアゾール−4−イ
ル)−2−ホルミルオキシイミノ酢酸(0,48g、
2. Omol)をDMF (3T1.l) l:溶解
し、炭酸水素ナトリウム(0,16g、2.Omol)
を水(3−)溶かし加えた。析出物を炉遇し、酢酸エチ
ルで洗浄し、五酸化リン上で減圧下、乾燥し無色結晶状
化合物として(Z)−2−(2−ホルミルアミノチアゾ
ール−4−イル)−2−ホルミルオキシイミノ酢酸ナト
リウム(0,26g、収率:49%)を得た。mp: 188-192℃ (decomposition) IR (KBr, disc, cr') 3200
.. 3110.2950.1775.1770.1745
.. 1700.1635.1555.1400, 1295
.. 1210.1120.1050゜955.865.7
5O NMR (DMSO-d6.δ) 8.16 (s, IH
) 8.31 (s, IH) 8.60 (IH, s)
Example 2 (Z)-2-(2-formylaminothiazol-4-yl)-2-formyloxyiminoacetic acid (0.48 g,
2. Dissolve Omol) in DMF (3T1.l) l: Sodium hydrogen carbonate (0.16g, 2.Omol)
was dissolved in water (3-) and added. The precipitate was heated, washed with ethyl acetate, and dried over phosphorus pentoxide under reduced pressure to give (Z)-2-(2-formylaminothiazol-4-yl)-2-formyloxy as a colorless crystalline compound. Sodium iminoacetate (0.26 g, yield: 49%) was obtained.
I R(KBr、 disc、、 cr’) 3525
.3520.3275.3125、1760、1675
.1640.1580.1465.1410.1295
.1225.1165.1125.1060.895.
850.790.745.735.67O
NMR(DMSO−d6.δ)8.17 (s、IH
)8.43 (s、IH)8.57 (s、IH)
実施例3
(Z)−2−(2−ホルミルアミノチアゾール−4−イ
ル)−2−ホルミルオキシイミノ酢酸(1,21g、
5.Ommol)をジクロロメチレン(80−)に溶か
し、−5℃に冷却し、五塩化リン(1,04g、5 、
5 mmol)を加え30分かくはんした。反応液をイ
ソプロピルエーテルに加え、析出物を濾過し、イソプロ
ピルエーテルで洗浄後、五酸化リン上で乾燥した。粉末
状化合物とじて(Z)−2−(2−ホルミルアミノチア
ゾール−4−イル)−2−ホルミルオキシイミノ酢酸ク
ロライド(1,17g、収率:90%)を得た。I R (KBr, disc,, cr') 3525
.. 3520.3275.3125, 1760, 1675
.. 1640.1580.1465.1410.1295
.. 1225.1165.1125.1060.895.
850.790.745.735.67O NMR (DMSO-d6.δ) 8.17 (s, IH
) 8.43 (s, IH) 8.57 (s, IH)
Example 3 (Z)-2-(2-formylaminothiazol-4-yl)-2-formyloxyiminoacetic acid (1,21 g,
5. Ommol) was dissolved in dichloromethylene (80-), cooled to -5°C, and phosphorus pentachloride (1.04 g, 5,
5 mmol) was added and stirred for 30 minutes. The reaction solution was added to isopropyl ether, and the precipitate was filtered, washed with isopropyl ether, and then dried over phosphorus pentoxide. The powdered compound was combined to obtain (Z)-2-(2-formylaminothiazol-4-yl)-2-formyloxyiminoacetic acid chloride (1.17 g, yield: 90%).
I R(KBr、 disc、、 Cm−’) 315
0.3075.3000.2950.1760.174
0.1715.1665.1555.1395.129
5.1260.1155.945.870.720.7
05
NMR(DMSO−d6.δ)8.00 (s、IH)
8.70 (s、IH) 9.00 (s、 IH)
参考例1
+1
しυ2Ctl(+’r122
CZ’)−2−ホルミルオキソイミノ−2−(2−ホル
ミルアミノチアゾール−4−イル)酢酸(3,79g、
15 、6 mmol)をジクロロメチレン(20mA
’に懸濁し、−5°Cに冷却した後、五塩化リン(3,
58g、17.2mmol)を加えた。反応液は30分
かくはんした。一方、7−アミノ−3−[(Z)−2−
(1,2,3−チアジアゾール−4−イル)エチニル]
−3−セフェムー4−カルボン酸ジフェニルメチル(5
,71g、12.Ommol)とBSA (12,7m
A!、 51.5mmol)から調製したジクロロメ
チレン(60mmol)溶液を5°Cに冷却した。つい
で、先の反応で調製した酸クロライドのジクロロメチレ
ン溶液を滴下した。3時間かくはんした後、水を加え、
ジクロロメチレンで抽出し、水、食塩水で洗浄した。硫
酸マグネシウムで乾燥し、濃縮し、残留物をインプロピ
ルエーテルで処理し、粉末状化合物としてジフェニルメ
チル7− [(Z)−2−(2−ホルミルアミノチアゾ
ール−4−イル)−2−ホルミルオキシイミノアセトア
ミド] −3−[(Z)−2’−(1゜2.3−チアジ
アゾール−4−イル)エチニルツー3−セフェム−4−
カルポキシレー) (7,56、g、収率:90%)を
得た。I R (KBr, disc,, Cm-') 315
0.3075.3000.2950.1760.174
0.1715.1665.1555.1395.129
5.1260.1155.945.870.720.7
05 NMR (DMSO-d6.δ) 8.00 (s, IH)
8.70 (s, IH) 9.00 (s, IH)
Reference Example 1 +1 υ2Ctl (+'r122 CZ')-2-formyloxoimino-2-(2-formylaminothiazol-4-yl)acetic acid (3,79 g,
15,6 mmol) in dichloromethylene (20 mA
', cooled to -5°C, and then suspended in phosphorus pentachloride (3,
58g, 17.2mmol) was added. The reaction solution was stirred for 30 minutes. On the other hand, 7-amino-3-[(Z)-2-
(1,2,3-thiadiazol-4-yl)ethynyl]
-3-cephemu-4-carboxylic acid diphenylmethyl (5
,71g,12. Ommol) and BSA (12,7m
A! , 51.5 mmol) in dichloromethylene (60 mmol) was cooled to 5°C. Then, the dichloromethylene solution of acid chloride prepared in the previous reaction was added dropwise. After stirring for 3 hours, add water,
Extracted with dichloromethylene, washed with water and brine. Dry over magnesium sulfate, concentrate, and treat the residue with inpropyl ether to give diphenylmethyl 7-[(Z)-2-(2-formylaminothiazol-4-yl)-2-formyloxy as a powdered compound. iminoacetamide] -3-[(Z)-2'-(1°2.3-thiadiazol-4-yl)ethynyl-3-cephem-4-
Carpoxyle) (7.56 g, yield: 90%) was obtained.
I R(KB r、 disc、、 cm”)3300
.3050.1780.1725.1685.1550
.1375.1225.1170.1015.760.
705゜
NMR(DMSO−d6. δ)3.56.3.65
(ABq、J=18Hz、2H) 、5.32(d、J
=5Hz、IH) 、5.97 (dd。I R (KB r, disc, cm”) 3300
.. 3050.1780.1725.1685.1550
.. 1375.1225.1170.1015.760.
705°NMR (DMSO-d6.δ) 3.56.3.65
(ABq, J=18Hz, 2H), 5.32(d, J
=5Hz, IH), 5.97 (dd.
J=5Hz、J=9Hz、IH)、6.69(cl、J
=12Hz、LH) 、6.77 (s、IH)、6.
87 (cl、J=12Hz、IH)、7.00〜7.
50 (m、l0H) 、7.37(s、IH) 、8
.50 (s、IH) 、8.96 (S、IH) 、
9.75 (s、IH) 、11.62 (bs、IH
) 、12.53 (bs。J=5Hz, J=9Hz, IH), 6.69(cl, J
=12Hz, LH), 6.77 (s, IH), 6.
87 (cl, J=12Hz, IH), 7.00-7.
50 (m, 10H), 7.37 (s, IH), 8
.. 50 (s, IH), 8.96 (S, IH),
9.75 (s, IH), 11.62 (bs, IH)
), 12.53 (bs.
IH)。IH).
参考例2−1
ジメチルホルムアミド(0,73g、 10.0111
1101)にオキシ塩化リン(0,46g、 3.0+
emol)を加え、50℃で30分かくはんした。この
混合物を0〜5℃に冷却し、(Z)−2−ホルミルオキ
シイミノ−2−(2−ホルミルアミノチアゾール−4−
イル)酢酸(0,48g、2.0II11101)を加
え1時間かくはんした。7−アミノ−3−[(Z)−2
−(1,2,3−チアジアゾール−4−イル)エチニル
コー3−セフェムー4−カルボン酸ジフェニルメチル(
0,48g、 2.Ommol)をジクロロメチレン(
3filA’)に溶解し、ピリジン(0,71g、 9
.Ommol)を加え室温で30分か(はんした。つい
で、先の反応で調製したジクロロメチレン溶液を0〜5
℃に冷却し、セフェム化合物の溶液を滴下した。5℃で
2.5時間かくはんし、水を加え、ジクロロメチレンで
抽出し、水、食塩水で洗浄した。硫酸マグネシウムで乾
燥し、濃縮し、残留物にイソプロピルエーテルを加え、
生成する沈殿を濾取し、乾燥し、粉末状化合物としてジ
フェニルメチル7−[(Z)−2−(2−ホルミルアミ
ノチアゾール−4−イル)−2−ホルミルオキシイミノ
アセトアミド] −3−[(Z)−2−(1,2,3−
チアジアゾール−4−イル)エチニルコー3−セフェム
ー4−カルボキシレート(0゜68g1収率;61%)
を得た。Reference Example 2-1 Dimethylformamide (0.73g, 10.0111
1101) and phosphorus oxychloride (0.46g, 3.0+
emol) was added and stirred at 50°C for 30 minutes. The mixture was cooled to 0-5°C and (Z)-2-formyloxyimino-2-(2-formylaminothiazole-4-
yl)acetic acid (0.48 g, 2.0II11101) was added and stirred for 1 hour. 7-amino-3-[(Z)-2
-(1,2,3-thiadiazol-4-yl)ethynylco-3-cephemu-4-carboxylic acid diphenylmethyl (
0.48g, 2. Ommol) to dichloromethylene (
3filA') and pyridine (0.71g, 9
.. Ommol) was added and allowed to stand at room temperature for 30 minutes.Then, the dichloromethylene solution prepared in the previous reaction was diluted with
It was cooled to 0.degree. C., and a solution of the cephem compound was added dropwise. The mixture was stirred at 5° C. for 2.5 hours, water was added, extracted with dichloromethylene, and washed with water and brine. Dry over magnesium sulfate, concentrate, add isopropyl ether to the residue,
The formed precipitate is collected by filtration and dried to give diphenylmethyl 7-[(Z)-2-(2-formylaminothiazol-4-yl)-2-formyloxyiminoacetamide]-3-[( Z)-2-(1,2,3-
Thiadiazol-4-yl)ethynylco-3-cephemu-4-carboxylate (0°68g1 yield; 61%)
I got it.
参考例2−2
しU2しtl(PlIJ2
参考例2−1の生成物(2,80g、4 、 Q ma
+ol)をTHF−MeOH(17mA’、1 : 1
)の混合溶媒に溶かし、5℃に冷却した後、オキシ塩化
リン(0,6g、4 、 Q m+aol)を加え3時
間か(はんした。反応液はイソプロピルエーテル(17
0+/)に加え、析出物を濾過した。イソプロピルエー
テルで洗浄し、乾燥し、所望の生成物(2,52g。Reference Example 2-2 Product of Reference Example 2-1 (2,80 g, 4, Q ma
+ol) in THF-MeOH (17 mA', 1:1
) and cooled to 5°C, phosphorus oxychloride (0.6 g, 4, Q m + aol) was added and allowed to stand for 3 hours. The reaction solution was dissolved in isopropyl ether (17
0+/) and the precipitate was filtered. Washed with isopropyl ether and dried to give the desired product (2.52 g.
収率:93%)を得た。この生成物をアニソール(2+
1.18.5mmol)に懸濁し、5℃に冷却し、トリ
フルオロ酢酸(5,7鳳L 74 mmal)を滴下し
た。5℃で2時間かくはん後、イソプロピルエーテル(
180■りに反応液を加えた。析出物を濾過し、イソプ
ロピルエーテルで洗浄後、乾燥し、7− [(Z)−2
−(2−アミノチアゾール−4−イル)−2−ヒドロキ
シイミノアセトアミド]−3−[(Z)−2−(1,2
,3−チアジアゾール−4−イル)エチニル]〜3−セ
フェムー4−カルボン酸のトリフルオロ酢酸塩(1,8
5g。Yield: 93%) was obtained. This product was converted into anisole (2+
1.18.5 mmol), cooled to 5° C., and trifluoroacetic acid (5.7 mmol 74 mmol) was added dropwise. After stirring at 5°C for 2 hours, isopropyl ether (
The reaction solution was added to 180 liters. The precipitate was filtered, washed with isopropyl ether, and dried to give 7-[(Z)-2
-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide]-3-[(Z)-2-(1,2
,3-thiadiazol-4-yl)ethynyl]~3-cephemu-4-carboxylic acid trifluoroacetate (1,8
5g.
収率・84%)を得た。A yield of 84% was obtained.
IR(KB r、 disc、、 cm”)3300.
3100.1780.1680.1600.1540.
1410.1360.1240.1200.1140.
1010.800.720゜NMR(DMSO−66、
δ)3.50(m、2H)、5.20 (d、J=4.
5Hz、LH) 、5゜76 (dd、J=4.5Hz
、J=9Hz。IR (KB r, disc, cm") 3300.
3100.1780.1680.1600.1540.
1410.1360.1240.1200.1140.
1010.800.720°NMR (DMSO-66,
δ) 3.50 (m, 2H), 5.20 (d, J=4.
5Hz, LH), 5°76 (dd, J=4.5Hz
, J=9Hz.
IH)、6.66 (d、J=12Hz、IH)、6.
89 (d、J=12Hz、IH)、7.36 (bs
、2H) 、9.00 (s、IH)、9.50 (d
、J=9Hz、IH)。IH), 6.66 (d, J=12Hz, IH), 6.
89 (d, J=12Hz, IH), 7.36 (bs
, 2H), 9.00 (s, IH), 9.50 (d
, J=9Hz, IH).
参考例3−1
(Z)−2−ホルミルオキシイミノ−2−(2−ホルミ
ルアミノチアゾール−4−イル)酢酸(0,31g、1
、30 mmol)をジクロロメチレン(10mlに
懸濁し、−5℃に冷却し、五塩化リン(0,42g、1
、 Ommol)を加えた。反応液は1時間かくはん
した。一方、ビバロイルオキンメチル7−アミノー3−
[(Z)−2−(1,2,3−チアジアゾール−4−
イル)エチニル]−3−セフェムー4−カルボキンレー
ト(0,42g、10 m+++ol)をジクロロチレ
ン(16calりに溶解し、ピリジン(0,12ml、
3.Ommol)を加え室温で20分かくはんした。Reference Example 3-1 (Z)-2-formyloxyimino-2-(2-formylaminothiazol-4-yl)acetic acid (0.31 g, 1
, 30 mmol) was suspended in dichloromethylene (10 ml, cooled to -5°C, and phosphorus pentachloride (0.42 g, 1
, Ommol) was added. The reaction solution was stirred for 1 hour. On the other hand, bivaloyluoquinemethyl 7-amino-3-
[(Z)-2-(1,2,3-thiadiazole-4-
yl)ethynyl]-3-cephemu 4-carboxylate (0.42 g, 10 m+++ol) was dissolved in dichloroethylene (16 cal), and pyridine (0.12 ml,
3. Ommol) was added and stirred at room temperature for 20 minutes.
ついで、先の反応で調製したジクロロメチレンを一10
℃に冷却し、セフェム化合物の溶液を滴下した。1時間
か(はんした後、水を加え、ジクロロメチレンで抽出し
た後、水、食塩水で洗浄した。硫酸マグネシウムで乾燥
し、濃縮し、残留物にイソプロピルエーテルを加え、生
成した沈殿を濾取し、乾燥し、粉末状化合物としてピバ
ロイルオキシメチル7− [(Z)−2−(2−ホルミ
ルアミノチアゾール−4−イル)−2−ホルミルオキシ
イミノアセトアミド]−3−[(Z)−2−(1,2,
3−チアジアゾール−4−イル)エチニル]−3−セフ
ェムー4−カルボキシレート(0,56g、収率:90
%)を得た。Next, dichloromethylene prepared in the previous reaction was diluted with
The mixture was cooled to 0.degree. C., and a solution of the cephem compound was added dropwise. After stirring for 1 hour, water was added, extracted with dichloromethylene, and washed with water and brine. Dry with magnesium sulfate, concentrate, add isopropyl ether to the residue, and filter the formed precipitate. Pivaloyloxymethyl 7-[(Z)-2-(2-formylaminothiazol-4-yl)-2-formyloxyiminoacetamide]-3-[(Z) -2-(1,2,
3-thiadiazol-4-yl)ethynyl]-3-cephemu 4-carboxylate (0.56 g, yield: 90
%) was obtained.
I R(K B r 、 disc、、 c m”)3
300.3100.1775.1670.1610.1
530.1400.1350.1230.1200.1
145.1010.805.710゜NMR(DMSO
−d6. δ)3.34.3.71(ABQ、 J
=18H2,2H) 、5.13(d、 J=5Hz
、 IH) 、5.78.5.90 (ABQ、
J=6H2,2H) 、5.95(dd、 J=9
.5Hz、 IH)、6.74(d、J=12Hz、
IH)、7.92 (d。I R (K B r , disc,, cm”) 3
300.3100.1775.1670.1610.1
530.1400.1350.1230.1200.1
145.1010.805.710°NMR (DMSO
-d6. δ) 3.34.3.71 (ABQ, J
=18H2,2H), 5.13(d, J=5Hz
, IH), 5.78.5.90 (ABQ,
J=6H2,2H), 5.95(dd, J=9
.. 5Hz, IH), 6.74(d, J=12Hz,
IH), 7.92 (d.
J=12Hz、 IH)、8.31 (bs、
IH) 、8.38 (s、IH)。J=12Hz, IH), 8.31 (bs,
IH), 8.38 (s, IH).
参考例3−2
++
参考例3−1で得た生成物(0,208g、032++
vol)を脱水THF (20+l) I:溶解シ、5
℃に冷却した後、2N塩酸を加え、1時間かくはんした
。反応液を炭酸水素ナトリウムでp H4に調製し、酢
酸エチルで抽出し、水洗後、飽和食塩水で洗浄し、硫酸
マグネシウムで乾燥した。溶媒を留去し、ピバロイルオ
キンメチル7−[(Z)−2−(2−アミノチアゾール
−4−イル)−2=ヒドロキシイミノアセトアミド]
−3−[(Z)−2−(1,2,3−チアジアゾール−
4−イル)エチニル]−3−セフェムー4−カルボキシ
レート(0,135g、収率ニア1%)を得た。Reference Example 3-2 ++ Product obtained in Reference Example 3-1 (0,208 g, 032++
vol) dehydrated THF (20+l) I: Dissolved, 5
After cooling to ℃, 2N hydrochloric acid was added and stirred for 1 hour. The reaction solution was adjusted to pH 4 with sodium hydrogen carbonate, extracted with ethyl acetate, washed with water, washed with saturated brine, and dried over magnesium sulfate. The solvent was distilled off and pivaloyluoquinemethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2=hydroxyiminoacetamide]
-3-[(Z)-2-(1,2,3-thiadiazole-
4-yl)ethynyl]-3-cephemu 4-carboxylate (0,135 g, yield near 1%) was obtained.
I R(KB r、 disc、、 cm”)3300
.2980.1780.1750.1710.1660
.1520.1360.1220,1120.980.
800゜
NMR(CD Cl 8. δ)1.18(s、9H
)、3.42.3.62 (ABQ、J=18Hz。I R (KB r, disc, cm”) 3300
.. 2980.1780.1750.1710.1660
.. 1520.1360.1220, 1120.980.
800°NMR (CD Cl 8. δ) 1.18 (s, 9H
), 3.42.3.62 (ABQ, J=18Hz.
2H) 、5.21 (Q、J=5Hz、IH)、5.
45 (bs、2H) 、5.80 (d、J=5Hz
、IH)、5.98 (dd、J=5Hz。2H), 5.21 (Q, J=5Hz, IH), 5.
45 (bs, 2H), 5.80 (d, J=5Hz
, IH), 5.98 (dd, J=5Hz.
J=9Hz、LH)、6.00 (d、J=12Hz、
IH)、6.84 (d、 J=12Hz。J=9Hz, LH), 6.00 (d, J=12Hz,
IH), 6.84 (d, J=12Hz.
IH)、7.14 (s、 IH) 、8.40
(s。IH), 7.14 (s, IH), 8.40
(s.
LH) 、11.06 (bs、 IH)。LH), 11.06 (BS, IH).
参考例4−1
(Z)−2−ホルミルオキシイミノ−2−(2−ホルミ
ルアミノチアゾール−4−イル)酢酸(0,31g、1
.30mmol)をジクロロメチレン(10ml)に懸
濁し、−5℃に冷却した後、五塩化リン(0,30g、
1.43mmol)を加えた。反応液は1時間かくはん
した。一方、7−アミノ−3−ビニル−3−セフェム−
4−カルボン酸ジフェニルメチル(0,39g、 1.
Ommol)をジクロロメチレン(4mA’)に溶解し
、BSA (0,74m1.3 、 Q mmol)を
加え室温で30分かくはんした。Reference Example 4-1 (Z)-2-formyloxyimino-2-(2-formylaminothiazol-4-yl)acetic acid (0.31 g, 1
.. After suspending phosphorus pentachloride (0.30 g,
1.43 mmol) was added. The reaction solution was stirred for 1 hour. On the other hand, 7-amino-3-vinyl-3-cephem-
Diphenylmethyl 4-carboxylate (0.39g, 1.
Ommol) was dissolved in dichloromethylene (4 mA'), BSA (0.74 ml, Q mmol) was added, and the mixture was stirred at room temperature for 30 minutes.
ついで、先の反応で調製したジクロロメチレン溶液を0
℃に冷却し、セフェム化合物の溶液を滴下した。1.5
時間かくはんした後、水を加え、ジクロロメチレンで抽
出した後、水、食塩水で洗浄した。硫酸マグネシウムで
乾燥し、濃縮し、残留物にイソプロピルエーテルを加え
、生成した沈殿を濾取し、乾燥し、粉末状化合物として
ジフェニルメチル7− [(Z) −2−(2−ホルミ
ルアミノチアゾール−4−イル)−2−ホルミルオキシ
イミノアセトアミド]−3−ビニル−3−セフェム−4
−カルホキシレーh(0,51g、収率:86%)を得
た。Next, the dichloromethylene solution prepared in the previous reaction was diluted with 0
The mixture was cooled to 0.degree. C., and a solution of the cephem compound was added dropwise. 1.5
After stirring for an hour, water was added, extracted with dichloromethylene, and washed with water and brine. It was dried over magnesium sulfate and concentrated, and isopropyl ether was added to the residue. The formed precipitate was collected by filtration and dried to give diphenylmethyl 7-[(Z)-2-(2-formylaminothiazole-) as a powdery compound. 4-yl)-2-formyloxyiminoacetamide]-3-vinyl-3-cephem-4
-carboxylene h (0.51 g, yield: 86%) was obtained.
I R(KB r、 disc、、 cm”)3300
.3050.1780.1720.1685.1560
.1370.1225.1200.1175.1010
.760,705゜
NMR(CDC] s、 δ:13.58.397(
ABq、 J=18Hz、 2H) 、5.27(
d、 J=5Hz、 IH) 、5.30 (d
。I R (KB r, disc, cm”) 3300
.. 3050.1780.1720.1685.1560
.. 1370.1225.1200.1175.1010
.. 760,705°NMR (CDC) s, δ: 13.58.397 (
ABq, J=18Hz, 2H), 5.27(
d, J=5Hz, IH), 5.30 (d
.
J=9Hz、 IH)、5.45 (d、 J=1
8Hz、 IH) 、5.99 (dd、 J=
5Hz、 J=9Hz、 IH)6.73 (d
d、 J=9Hz、 J=18Hz、 IH)
、6.93(s、 IH)、7.17〜7.67
(m、 10H)、12.60(d、J=18Hz、
IH)。J=9Hz, IH), 5.45 (d, J=1
8Hz, IH), 5.99 (dd, J=
5Hz, J=9Hz, IH)6.73 (d
d, J=9Hz, J=18Hz, IH)
, 6.93 (s, IH), 7.17-7.67
(m, 10H), 12.60 (d, J=18Hz,
IH).
参考例4−2
参考例4−1の生成物(0,50g、0.85+u+o
l)をTHF−MeOHC4mL 1 : 1)の混合
溶媒に溶かし、5℃に冷却した後、オキシ塩化リン(0
,13g、 0.85mmol)を加え1.5時間かく
はんした。反応液はイソプロピルエーテルに加え、析出
物を濾過した。イソプロピルエーテルで洗浄し、乾燥し
た。この生成物をアニソール(2,5mA’)に懸濁し
、5℃に冷却し、トリフルオロ酢酸(6mA’)を滴下
し、5℃で1時間かくはん後、イソプロピルエーテル中
に反応液を加えた。Reference Example 4-2 Product of Reference Example 4-1 (0.50 g, 0.85+u+o
1) in a mixed solvent of THF-MeOHC (4 mL 1:1), cooled to 5°C, and dissolved in phosphorus oxychloride (0
, 13 g, 0.85 mmol) and stirred for 1.5 hours. The reaction solution was added to isopropyl ether, and the precipitate was filtered. Washed with isopropyl ether and dried. This product was suspended in anisole (2.5 mA'), cooled to 5°C, trifluoroacetic acid (6 mA') was added dropwise, and after stirring at 5°C for 1 hour, the reaction solution was added to isopropyl ether.
析出物を濾過し、イソプロピルエーテルで洗浄後、乾燥
した。この生成物を水に懸濁し、炭酸水素ナトリウムで
pH6,0に調製した後、不溶物を濾過した。濾液を水
冷し、2N塩酸でpH2,5に調製し、析出物を濾過し
た。水洗後、乾燥し、粉末状化合物として7− [(Z
)−2−(2−アミノチアゾール−4−イル)−2−ヒ
ドロキシイミノアセトアミド〕−3−ビニル−3−セフ
ェム−4−カルボン酸(0,072g、収率:22%)
を得た。The precipitate was filtered, washed with isopropyl ether, and then dried. This product was suspended in water, adjusted to pH 6.0 with sodium hydrogen carbonate, and then filtered to remove insoluble matter. The filtrate was cooled with water, adjusted to pH 2.5 with 2N hydrochloric acid, and the precipitate was filtered. After washing with water and drying, 7-[(Z
)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamide]-3-vinyl-3-cephem-4-carboxylic acid (0,072 g, yield: 22%)
I got it.
I R(KB r、 disc、、 cm”)3325
.3100.1775.1690.1625.1570
.1525.1415.1400,1360、Z305
.1245.1180.1140.1015.900.
810,780.7501600.560゜
NMR(DMSO−d 6. δ)3.52.3.8
4(ABq、J=18Hz、2H) 、5.18(d、
J=5Hz、 IH) 、5.30 (cl。I R (KB r, disc, cm”) 3325
.. 3100.1775.1690.1625.1570
.. 1525.1415.1400,1360,Z305
.. 1245.1180.1140.1015.900.
810,780.7501600.560°NMR (DMSO-d 6. δ) 3.52.3.8
4(ABq, J=18Hz, 2H), 5.18(d,
J=5Hz, IH), 5.30 (cl.
J=11Hz、 IH) 、5.38 (d、
J=18Hz、 IH) 、5.79 (dd
、 J=5Hz、 J=9Hz、 IH) 、6
.68 (s。J=11Hz, IH), 5.38 (d,
J=18Hz, IH), 5.79 (dd
, J=5Hz, J=9Hz, IH), 6
.. 68 (s.
IH) 、6.93 (dd、 J=11Hz、
J=18Hz、 LH) 、7.10 (S、
IH) 、9.48 (d、 J=9Hz、
IH)。IH), 6.93 (dd, J=11Hz,
J=18Hz, LH), 7.10 (S,
IH), 9.48 (d, J=9Hz,
IH).
Claims (1)
アミノチアゾール−4−イル)酢酸並びにその塩及び反
応性誘導体。 2、Z−異性体である請求項第1項記載の化合物。[Claims] 1. Formyloximino-2-(2-formylaminothiazol-4-yl)acetic acid represented by the formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (I) and its salts and reactive derivatives . 2. The compound according to claim 1, which is the Z-isomer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2298660A JPH04173781A (en) | 1990-11-02 | 1990-11-02 | Thiazoleacetic acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2298660A JPH04173781A (en) | 1990-11-02 | 1990-11-02 | Thiazoleacetic acid derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04173781A true JPH04173781A (en) | 1992-06-22 |
Family
ID=17862617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2298660A Pending JPH04173781A (en) | 1990-11-02 | 1990-11-02 | Thiazoleacetic acid derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04173781A (en) |
-
1990
- 1990-11-02 JP JP2298660A patent/JPH04173781A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4856795B2 (en) | Novel salts in the production of cephalosporin antibiotics. | |
EP0175814B1 (en) | Process for preparing cephem derivatives | |
JP4022070B2 (en) | Novel thiazole compound and method for producing the same | |
JPH0834744B2 (en) | Novel cephalosporin intermediate | |
EP1268488B1 (en) | A process for preparing cephalosporin derivatives using new thiazole compound | |
US4297279A (en) | Imidazoledicarboxylic acid derivative | |
HU213267B (en) | Process for producing stereospecific cefepime-dihydrochloride-hydrate at ph 5-7,5 | |
HU212782B (en) | Water-free acylating process for stereospecifical producing antibioticum cephepim-dihydrochloride-hydrate | |
JPH04173781A (en) | Thiazoleacetic acid derivative | |
US5162522A (en) | Method for producing cephem compounds | |
JP2602669B2 (en) | Method for producing 2β-halogeno-substituted methylpenicillin derivative | |
US4091214A (en) | De-esterification process for cephalosporins | |
US4433142A (en) | Process for the preparation of 7-(2-amino-2-phenylacetamido) cephem derivatives | |
JP2005508385A (en) | Method for producing cephalosporin side chain | |
JPS63503072A (en) | New and improved synthetic method for penicillanic acid derivatives | |
US4286088A (en) | Process for preparing 7-aminocephalosporins | |
KR810000635B1 (en) | Process for preparing cephalosporin compounds | |
KR890001282B1 (en) | Process for preparing 3-vinyl cephalosporin derivatives | |
JP3217541B2 (en) | Method for producing guanine derivative | |
JPH0354108B2 (en) | ||
KR890002215B1 (en) | Process for preparing cephem derivatives | |
US20020016457A1 (en) | Process for preparing cephalosporin antibiotics using new thiazole compound | |
KR840000799B1 (en) | Process for preparing penicillin compounds | |
HU192983B (en) | Process for production of cefem compounds | |
JPH0546354B2 (en) |